Phenylbutyrate/Genistein Duotherapy in Delta F508-Homozygous(for Cystic Fibrosis)

NCT00016744 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Sodium 4-Phenylbutyrate (4PBA)
DRUG: Unconjugated Isoflavones 100 (PTI G-4660, 87% Genistein)
DRUG: Placebo

Sponsor

Children's Hospital of Philadelphia

Collaborators

[object Object]
[object Object]